Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
clinical trials
life sciences
national blog main
national top stories
deals
fda
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
acorda therapeutics
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
ampyra
angelman syndrome
apokyn
apomorphine
athenex
biofourmis
biomarin pharmaceutical
biotech
biovotion
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
chugai pharmaceutical
competitive generic therapy
cystic fibrosis
dalfampridine
detroit blog main
detroit top stories
duopa
What
help
3
×
patients
3
×
drug
fda
acorda
analytics
approved
aren’t
bio
biofourmis
cope
data
developers
devices
digital
disease
drugs
employs
episodes
friday
gene
gets
globally
hauls
imminent
late
long
looms
meant
medicare
medications
million
moves
new
news
nod
noteworthy
parkinson’s
prices
raised
Language
unset
Current search:
patients
×
help
×
" boston blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
